89bio
在场
高管
查看带有其 23 名主要高管的组织结构图
89bio 搜索最多的简介
- Rohan Palekar, Chief Executive Officer and Director
- Derek Dirocco, Director
- Morrey Atkinson, Director
高管在89bio变化
- Teresa Perney已作为Chief Regulatory and Quality Officer加入公司 (新闻发布的2024九月17号).
- Francis Sarena已作为Chief Operating Officer加入公司 (新闻发布的2024八月8号).
- Charles McWherter已作为Director加入公司 (新闻发布的2024八月6号).
创建提醒
跟踪 89bio 的高管变动
生物技术
89bio 拥有 2,332 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- March Biosciences 刚刚宣布为 28 筹款数百万美元。 (公布2024十二月3号).
- Lyell Immunopharma 已收购 ImmPACT Bio (公布2024十一月29号).
- Hopo Therapeutics 刚刚宣布为 226 筹款数百万美元。 (公布2024十一月29号).
生物技术 行业的其他推荐联系人
消息
89bio 的最新新闻稿
- 89bio to Participate in the 6th Annual Evercore ISI HEALTHCONx Conference | 89bio, Inc.
- Press Releases | 89bio, Inc.
- 89bio Announces Additional Data from the ENLIVEN Phase 2b Trial of Pegozafermin in Patients with Compensated Cirrhotic (F4) Nonalcoholic Steatohepatitis (NASH) at AASLD The Liver Meeting® 2023 | 89bio, Inc.
- 89bio Reports Third Quarter 2023 Financial Results and Provides Corporate Updates | 89bio, Inc.
- 89bio Announces U.S. FDA has Granted Breakthrough Therapy Designation for Pegozafermin in Nonalcoholic Steatohepatitis (NASH) | 89bio, Inc.
- 89bio to Participate in the H.C. Wainwright 7ᵗʰ Annual NASH Investor Conference | 89bio, Inc.
- 89bio to Participate in the 2023 Cantor Global Healthcare Conference | 89bio, Inc.
- 89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 89bio, Inc.
- 89bio to Participate in the H.C. Wainwright 25th Annual Global Investment Conference | 89bio, Inc.
- 89bio Reports Second Quarter 2023 Financial Results and Provides Corporate Update | 89bio, Inc.
- View more press releases Close
通过电子邮件
